Mylab rolls out new in vitro diagnostic medical devices and kits for small labs in India

Its range of devices includes ones with haematology, microbiology, immunology, blood grouping and many other applications, the company said.

HIV, HIV AIDS, oral tests, oral fluids, HIV self-tests, diagnostics news, healthcare news,
INVEX Health is also establishing itself and creating the largest platform for cancer therapy in India.

Mylab Discovery Solutions on Thursday announced it is all set to roll out new in vitro diagnostic (IVD) medical devices and kits range to empower small labs across the country.

According to the diagnostics company, these devices and reagents, are specially designed to enable small to medium size laboratories and physicians’ clinics to perform diagnoses at their facilities, without having to send samples to central labs or other cities, which increases the risk of spoiled samples and delayed reporting.

“Small labs, since decades, have been using devices designed for big labs with high work load. Therefore, labs and physicians with low workload had to collect samples and then send them in batches to central labs which are often not in the same city. This results in a long delay between sample collection and analysis. Mylab is introducing conventional diagnostic solutions to create a decentralized diagnostic ecosystem where the lab near you will be able to offer quality diagnostics at faster turn-around,” the company stated on Thursday.

According to the company, the diagnostics compLabs in semi-urban and rural areas in India can now offer specialised tests to patients. This will help patients from remote areas to access specialised tests easily at their home locations and avail timely treatment.

The company is doing this by offering devices which have smaller reagent packs, smaller sample volume requirements, better sensitivity, linearity and are point of care and high throughput. Another interesting technology is that now consumers will be able to a detect accurate levels of natural vitamins levels (Biotin) even if an individual is consuming vitamin supplements.

“We have understood the gaps in existing offerings by existing IVD players and we are now well- positioned to empower laboratories with accelerated, cost-effective conventional IVD tests that can give results faster to physicians treating the patient. We plan to offer smaller, value for money packs of reagents for labs to drive volumes as was done by FMCG companies with their products”, said Rajesh Patel, Executive Director, Mylab.

Its range of devices includes ones with haematology, microbiology, immunology, blood grouping and many other applications, the company said. The company plans to roll out pan India through its network of distributors, and a highly trained and experienced sales force of more than 150 people, it added.

Get live Share Market updates, Stock Market Quotes, and the latest India News and business news on Financial Express. Download the Financial Express App for the latest finance news.

This article was first uploaded on February ten, twenty twenty-three, at fifty-four minutes past one in the afternoon.
shorts
Italy’s Meloni responds to Turkey’s Erdogan’s quit-smoking advice – VIDEO
Italy’s Meloni responds to Turkey’s Erdogan’s quit-smoking advice – VIDEO
Trending News18 min ago

As world leaders gathered in Egypt’s Sharm el-Sheikh for the Gaza peace summit, a light exchange between Turkish President Recep Tayyip Erdogan and Italian Prime Minister Giorgia Meloni stole the spotlight.

Market Data
Market Data